0001209191-19-024315.txt : 20190410 0001209191-19-024315.hdr.sgml : 20190410 20190410194537 ACCESSION NUMBER: 0001209191-19-024315 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190408 FILED AS OF DATE: 20190410 DATE AS OF CHANGE: 20190410 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Popovits Kimberly J CENTRAL INDEX KEY: 0001333482 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-51541 FILM NUMBER: 19742613 MAIL ADDRESS: STREET 1: 301 PENOBSCOT DRIVE CITY: REDWOOD CITY STATE: CA ZIP: 94063 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GENOMIC HEALTH INC CENTRAL INDEX KEY: 0001131324 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 770552594 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 301 PENOBSCOT DRIVE CITY: REDWOOD CITY STATE: CA ZIP: 94063 BUSINESS PHONE: 650-556-9300 MAIL ADDRESS: STREET 1: 301 PENOBSCOT DRIVE CITY: REDWOOD CITY STATE: CA ZIP: 94063 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-04-08 0 0001131324 GENOMIC HEALTH INC GHDX 0001333482 Popovits Kimberly J 301 PENOBSCOT DR. REDWOOD CITY CA 94063 1 1 0 0 President and CEO Common Stock 2019-03-29 5 G 0 E 7000 0.00 D 118952 I Held by the Popovits 2010 Trust Common Stock 2019-04-08 4 S 0 7536 66.7216 D 111416 I Held by the Popovits 2010 Trust Common Stock 2019-04-08 4 S 0 2364 67.545 D 109052 I Held by the Popovits 2010 Trust Common Stock 2019-04-08 4 S 0 100 68.31 D 108952 I Held by the Popovits 2010 Trust Common Stock 12298 I Held by Morgan Stanley as Custodian for Benefit of Kimberly Popovits Common Stock 36168 D These sales of common stock were effected pursuant to Rule 10b5-1 sales plan adopted by the reporting person on December 10, 2018. Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated. Represents weighted average sale price. Actual sale prices ranged from $66.29 to $67.25. Represents weighted average sale price. Actual sale prices ranged from $67.30 to $68.03. Represents actual sale price. Represents shares of common stock issuable pursuant to previously reported restricted stock units that have not vested. /s/ Jason W. Radford, Attorney-in-fact 2019-04-10